Lucknow, India

Sonam Kanchan

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sonam Kanchan

Introduction

Sonam Kanchan is a notable inventor based in Lucknow, India. He has made significant contributions to the field of medicinal chemistry, particularly in the management of benign prostatic hyperplasia (BPH). His work focuses on the isolation and preparation of beneficial compounds derived from natural sources.

Latest Patents

Sonam Kanchan holds a patent for "Chebulinic acid and its enriched fraction from the fruits for treatment of benign prostatic hyperplasia (BPH) and its preparation thereof." This invention highlights the beneficial effects of Chebulinic acid (CA) and its enriched standardized fraction (CAEF) isolated from specific fruits. The patent describes a novel and economically viable method for isolating Chebulinic acid and ellagic acid from dried and powdered fruits without the need for expensive chromatographic techniques.

Career Highlights

Sonam Kanchan is associated with the Council of Scientific and Industrial Research, where he has been involved in various research projects. His innovative approach to isolating natural compounds has garnered attention in the scientific community. He has successfully contributed to the advancement of treatments for BPH through his research.

Collaborations

Some of his notable coworkers include Narender Tadigoppula and Monika Sachdev. Their collaborative efforts have further enhanced the research output and innovation in their field.

Conclusion

Sonam Kanchan's work exemplifies the importance of innovation in the field of medicinal chemistry. His contributions, particularly in the treatment of benign prostatic hyperplasia, showcase the potential of natural compounds in modern medicine. His patent reflects a significant step forward in the development of effective treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…